tirzepatide is a glp 1 FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Beyond glycemia: Comparing tirzepatide to
Description
Clinical trials demonstrate average weight reductions of approximately 15% with semaglutide 2.4 mg (STEP 1 trial) and 20-22.5% with tirzepatide 10-15 mg (SURMOUNT-1 trial) over 68-72 weeks
Cost and Insurance Coverage Semaglutide can be expensive, especially without insurance coverage
Wegovy (Semaglutide Injection): A weekly injection with proven efficacy, helping patients achieve average weight losses of up to 15% over 68 weeks
Vaginal speculum examination: Is there any vaginal atrophy, discharge, cervical lesions, i.e., polyps, suspicion of cancer
Face-to-face conversation catches nuances that digital forms miss
Ozempic may transfer into breast milk, and experts advise against use during lactation due to unknown effects on infant development
